The isotope dilution method has been useful in measuring either secretion rates or production rates of several important steroid hormones. This technique consists of measuring the dilution of a tracer amount of hormone into the plasma pool from the cumulative specific activity of a unique urinary metabolite of that pool. If the plasma pool is derived entirely from glandular secretion of the hormone, then a secretion rate is measured. If, however, both glandular secretion and peripheral conversion of one or more precursors contribute to this pool, then a production rate is measured. In either case the validity of the method depends strictly upon the presence of a urinary metabolite uniquely derived from the pool in question. Since it has generally been assumed that a steroid hormone conjugate would be such a unique metabolite, secretion rates of aldosterone and, in women, estradiol have been measured in this way.
The isotope dilution method has been useful in measuring either secretion rates or production rates of several important steroid hormones. This technique consists of measuring the dilution of a tracer amount of hormone into the plasma pool from the cumulative specific activity of a unique urinary metabolite of that pool. If the plasma pool is derived entirely from glandular secretion of the hormone, then a secretion rate is measured. If, however, both glandular secretion and peripheral conversion of one or more precursors contribute to this pool, then a production rate is measured. In either case the validity of the method depends strictly upon the presence of a urinary metabolite uniquely derived from the pool in question. Since it has generally been assumed that a steroid hormone conjugate would be such a unique metabolite, secretion rates of aldosterone and, in women, estradiol have been measured in this way.
In discussing an isotope dilution method (1) for measuring the testosterone production rate (TPR), we considered the possibility that testosterone glucuronoside (TG) may not be a unique metabolite of the plasma testosterone (T) pool. This situation could arise as follows: It has been shown that T can be synthesized peripherally from both androstenedione (A) and dehydroepiandrosterone (D) (2) (3) (4) (5) . Presumably this transformation occurs in the liver, and indeed this has been demonstrated by perfusion studies with dog liver (6) . When T is synthesized either in the liver or at any other peripheral site, if conjugation occurs before entry of this T into plasma some TG will be excreted that is not derived from plasma T. This concept is diagrammed in Figure 1 . The portion within the dotted line represents that hypothetical moiety of T derived from A, which is conjugated immediately. We have designated this route the A -> TG pathway.
The following studies were undertaken to test for the existence of this pathway and evaluate its quantitative significance. Androstenedione-H3 and T-C14 were infused, and the H3/C14 ratios of free and conjugated T were compared. If all the T derived from A re-entered the plasma as free T, then the H3/C14 ratio of free and conjugated T should become equal as metabolism proceeds towards completion. Conversely, if all the T synthesized from A underwent immediate conjugation, plasma free T would contain no tritium. Our results indicate that the A -+ TG pathway exists, that it may contribute substantially to urinary TG, and therefore that urinary TG is not a unique metabolite of the plasma T pool. Thus the TPR must overestimate production of plasma T.
Methods
The methods of isolating urinary T and measurement of the TPR have been described (1, 7) . Testosterone-4-C1' 1 was chromatographed on paper in the Bush type system, ligroin: methanol: water (10: 7: 3), followed by thin-layer chromatography in the system, benzene: ethyl acetate (3: 2). Androstenedione-1,2-H' 1 was purified by thin-layer chromatography in benezene: ethyl acetate (3: 2) before use.
Free T was isolated from plasma as follows: Plasma was separated from red cells within an hour of completion of the experiment, and 200 ,sg of T was added to each sample. After the addition of 1 ml of 1 N NaOH per 40 ml plasma, the plasma was extracted twice with 3 vol ether: chloroform (3:1). After washing with * and X:& vol of H20, the ether-chloroform was dried over Na2SO4 and evaporated. The free T was then isolated by thin-layer and paper chromatography as described for urinary T.
To isolate TG the spent plasma and combined aqueous washes were mixed with 5 vol of absolute ethanol. Simultaneous counting of H3 and C"4 was carried out in the Packard Tri-Carb liquid scintillation spectrometer, model 314 EX, in toluene, 2,5-diphenyloxazole, and 1-4-bis-2-(5-phenyloxazolyl) benzene fluor with discriminator and gain settings such as to allow less than 0.3%o of the H3 counts to enter the C'4 channel. Unless otherwise indicated, the errors of the H3/C'4 ratios were less than 5% at the 95%o confidence limits. On occasion, because of low counting rates, the total sample was used and the labeled steroid recovered from the counting vials by thin-layer chromatography and used for further analyses.
The reverse isotope dilution experiments were performed by adding 200 Ag of T to 10%o aliquots of the urine samples, isolating the urinary T in the usual fashion, and assaying for radioactivity and recovery. Since TG was not available, we assumed 100% hydrolysis of urinary TG in our calculations. After the simultaneous intravenous administration of A-H3 and of T-C", blood was removed by plasmapheresis into heparinized bags, centrifuged, and the plasma extracted on completion of the experiment. Urine was collected for the subsequent 48 hours and stored at -14°C until processed. Details of the time of plasmapheresis and the amounts of plasma obtained are given in Tables I, II, and IV. Subject H.F. was a 36-year-old man with generalized psoriasis who was otherwise in good health. M.L., a 23-year-old woman, was in good health 4 months after chemotherapy for persistent hydatidiform mole. C.T. was a 36-year-old man with a 1-year diagnosis of mycosis fungoides. There was no evidence of systemic disease or hepatic damage. J.P., a 54-year-old man with panhypopituitarism, was receiving replacement doses of cortisone, desiccated thyroid, and fluoxymesterone.
Results
Experiment 1: H.F. This study was designed to compare the H3/C14 ratio of urinary TG with the maximal plasma T ratio. Accordingly, after the administration of 6 x 107 dpm of A-H3 and 2 X 106 dpm of T-C'4, plasma was collected at intervals between 10 and 58 minutes (Table I) and maximal H3/C14 ratio in plasma T should be studied by measuring the H3/C14 ratios in plasma attained when A metabolism is largely complete T, plasma TG, and urinary TG, as well as deand both isotopes are undergoing the same expo-termining the TPR and the excretion of urinary nential decline. In Table I , it is apparent that by TG. After the administration of 6 x 107 dpm of 21 minutes the final ratio had been reached. In A-H3 and 2 x 106 dpm of T-C14, plasma was general, the H3/C'4 ratios of successive deriva-obtained as indicated in Table II , and urine was tives agreed closely. The H3/C14 ratio of urinary collected for the first 8 and subsequent 40 hours. TG determined from the 48-hour collection was Samples from each urinary collection were used 11.5. This is significantly higher than the aver-to measure the total T excretion by reverse isoage final plasma ratio of 7.4, indicating that some tope dilution. H3 had entered urinary TG without passing In Table II , the H3/Cl4 ratios in plasma T and through the plasma T pool. From the excess of TG are presented for both C.T. and M.L. at two H3 in the urinary TG it was calculated that about time intervals. In each TG fraction the H3/C14 one-third of the urinary TG derived from A was was four to seven times that of the corresponding formed via the A-> TG pathway. and 87%o of the radioactivity in T were excreted. The urinary H3/C14 ratios at this time were 9.4 and 9.5. In M.L., this agreed with the final plasma ratio of 9.4, whereas in C.T. the plasma TG ratio was only 7.8. The TPR's of 3.2 and 1.3 mg per day were within the expected ranges. The total conversion of A to TG was 0.37%o and 0.24%o in C.T. and M.L., respectively, with corresponding T to TG conversions of 1.16% and 0.68%o. The elevated H3/C14 ratios in the urinary TG excreted between 8 and 48 hours after isotope administration indicate that some of the A metabolized to T was slowly released from some intracellular pool. This component constituted only a small fraction of the total radioactivity excreted. Experimenft 3: J.P. In this study after the administration of 4 X 10' dpm of A-H3 and 106 dpm of T-C14, successive plasma H3/C'4 ratios were compared with the ratio in urine after prior extraction of urinary free T with ether. The maximal plasma T H3/C14 ratio was reached more slowly in this subject (Table IV) . Additional derivatives of plasma T could not be made because of low counting rates. Nevertheless the ratios as T and A agreed well. The ratio in urinary TG was the same as that of the last plasma sample, indicating that the A -* TG pathway did not contribute significantly to urinary TG. The TPR of 0.68 mg per day was compatible with the diagnosis of hypopituitarism.
Discussion
The production of T from A in peripheral tissues has been inferred by Vande Wiele, MacDonald, Gurpide, and Lieberman (8) in their studies based on the specific activities of urinary steroid metabolites and has been directly demonstrated by Mahesh, Greenblatt, Aydar, and Roy (2) and by Baulieu and Robel (3) . In all four of our studies, Hf3 was found in plasma T, confirming the peripheral production of a hormone from an inactive precursor.
The excess of H3 in the plasma TG in both subjects indicated that most of the TG synthesized from A had been derived via the A -/ TG pathway. This demonstrates that some T formed peripherally is conjugated immediately and thus never enters the plasma as T. Therefore, urinary TG is not a unique metabolite of plasma T. Lindner (9) has found that T may be synthesized from A by incubation of A with human whole blood. If this occurred to any significant extent in our studies, then the effect would be to increase the H3/C14 ratio of plasma T and therefore decrease the relative proportion of the A -* TG pathway. Since plasma TG had a much higher H3/C14 ratio than plasma T, it is unlikely that much A-H3 was directly converted to T in the plasma during the course of the study.
To illustrate the disproportionate influence of the A -* TG pathway on the estimate of T production by the urinary isotope dilution method, we have assumed A production rates of 3,000 MAg per day for M.L. and 5,000 ug per day for C.T. and calculated T secretion and production rates (Figures 2 and 3 ). In the case of M.L., since 0.24% of administered A was excreted as TG, 7.2 Mug per day of her urinary TG would have been derived from A and 1.45 derived from T secretion. From the plasma T H3/C14 of 1.6 and urinary ratio of 10.5, we calculated that the A -/TG pathway was responsible for 85% of the A excreted as TG or 6.13 ug. The remaining 1.07 ug, derived from A, passed through the plasma T pool.
Since 0.68% of T-C'4 was excreted as urinary TG (Table III) , the T secretion would be 214 Mg (1.45/0.0068) and the T production from A 158 Mg (1.07/0.0068). The estimated total production of T of 214 + 158 = 372 Mg per day was much lower than the estimate of 1.3 mg per day obtained by the dilution of T-C14 in urinary TG.
The data in Figure 3 were derived similarly except that an A production rate of 5 mg per day was assumed. With these data, the production of plasma T was 1.77 mg per day, whereas the TPR measured by urinary dilution was 3.2 mg per day.
In both cases, the H3/C14 ratio of plasma TG was approaching that of urinary TG. Therefore the free plasma T ratio is not far from its maximal value. Since the percentage of-TG not derived from T was calculated by the formula, (RTG-RT X 100)/RTG, where R = H3/C14, it is clear that this value is rather insensitive to small changes in RT when RTG is much higher than RT.
Several assumptions have been made in the construction and interpretation of the models in Figures 2 and 3 . These assumptions are: 1) The A production rate values of 3 and 5 mg per day are reasonable. Vande Wiele and his associates (8) estimated A production rates in several subjects and arrived at higher values than those we used. Any increase in the estimated A production rate would tend to increase the contribution of the A -> TG pathway to urinary TG and thus make the production of plasma T even smaller. However, these calculations are very sensitive to small changes in A production rate; e.g., an increase of estimated A production of M.L. from 3 to 3.5 mg per day would entirely eliminate T secretion. 2) The disposal of exogenous A-H3 is the same as that of endogenous A. Although this assumption would not have been questioned in the past, it is no longer certain that a labeled steroid mixes completely with the steroid being produced in the liver. Since most of A is probably derived from D, quite possibly a portion of this A, synthesized in the liver, may undergo further metabolism before entering the plasma. In this case, only a fraction of A production would be available for conversion to T, a situation exactly analogous to that which we have described for T. This would have the effect of reducing the percentage of conversion of A to T to less than that found by administration of exogenous A-H3, thereby decreasing the significance of the A TG pathway.
3) It has been assumed that TG is an end product and is not further metabolized. The fate of steroid glucuronosides has been rigorously examined only for androsterone glucuronoside (10), which did not undergo further metabolism.
4 However, when the secretion rate of T is high, the relative contribution of A --TG pathway to urinary TG becomes smaller, and the TPR approaches the plasma T production. Thus, in young men the TPR is probably not greatly in error and may be useful in physiological studies. We have, for instance, shown that the TPR increases when human chorionic gonadotropin is given (1) and decreases under the influence of androgen (11) .
In women, however, T secretion may be very low so that the TPR substantially overestimates the production of T as in Figure 2 . Significant increases in T secretion or production could be easily masked by a smaller contribution of the A -TG pathway to urinary TG.
Our demonstration of the A -> TG pathway has a parallel in studies of the production rate of progesterone described by Tait (12) . The secretion rate of progesterone was determined both by the metabolic clearance method and from the specific activity of urinary pregnanediol. It was postulated that intrahepatic conversion of steroid precursors to progesterone occurred and that some of this progesterone was metabolized to pregnanediol before entry into the plasma. Thus, in this case pregnanediol was not a unique metabolite of plasma progesterone. A similar situation could exist in the measurement of estrogen production rates in men and ovariectomized women, since most of the estrogen may be synthesized peripherally from T or A.
This peripheral synthesis and immediate conjugation of a steroid is of physiologic significance in those instances when the steroid is a hormone. In such cases, the determination of the plasma levels of the hormone will provide a better measure of the hormonal state than the measurement of the production rate. Since a glucuronoside of a steroid hormone can no longer be assumed a unique metabolite of the plasma pool of that hormone, the use of such metabolites for production rate measurements must be experimentally validated. Under conditions in which peripheral interconvertibility of steroids may be demonstrated, evaluation of side pathways may profitably be undertaken with the experimental design herein described. Furthermore, our demonstration of at least two T compartments emphasizes the need for caution in the acceptance of new metabolic pathways that may be demonstrated by isotope dilution when a single compartment is assumed.
Summary
Since androstenedione is converted to testosterone peripherally, studies were performed to test the assumption that urinary testosterone glucuronoside is a unique metabolite of plasma testosterone. It was shown that some testosterone derived from androstenedione peripherally is conjugated to the glucuronoside without ever entering the plasma as testosterone. Thus, urinary testosterone glucuronoside is not a unique metabolite of plasma testosterone.
A consequence of this is that testosterone production rates measured by dilution of labeled testosterone in urinary testosterone glucuronoside overestimate the testosterone production to a variable extent. The demonstration of multiple metabolic steps before mixing in the plasma pool is of general importance in the evaluation of production rates and in the consideration of new metabolic pathways.
